<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1_25">
 <label>TABLE 25-1</label>
 <caption>
  <p>High risk conditions associated with life-threatening H1N1 infection</p>
 </caption>
 <table frame="hsides" rules="groups">
  <tbody>
   <tr>
    <td>1. Neurological disorders, such as epilepsy, cerebral palsy, developmental delay and Â­neuromuscular disorders</td>
   </tr>
   <tr>
    <td>2. Chronic respiratory diseases associated with impaired pulmonary function and/or difficulty handling lung secretions, moderate and especially severe persistent asthma, technology-dependent children (e.g., those requiring oxygen, tracheostomy, or a ventilator)</td>
   </tr>
   <tr>
    <td>3. Primary immunodeficiencies or conditions that require medications or treatments that result in secondary immunodeficiencies</td>
   </tr>
   <tr>
    <td>5. Congenital heart disease</td>
   </tr>
   <tr>
    <td>6. Metabolic (e.g., mitochondrial) or endocrine disorders, especially if cardiopulmonary function is impaired</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>Adapted from 
   <ext-link ext-link-type="uri" xlink:href="http://www.aap.org/new/swineflu.htm" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.aap.org/new/swineflu.htm</ext-link>
  </p>
 </table-wrap-foot>
</table-wrap>
